Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BEAT

HeartBeam (BEAT) Stock Price, News & Analysis

HeartBeam logo

About HeartBeam Stock (NASDAQ:BEAT)

Advanced Chart

Key Stats

Today's Range
$2.10
$2.30
50-Day Range
$71.46
$72.27
52-Week Range
$1.17
$3.48
Volume
118,715 shs
Average Volume
104,134 shs
Market Capitalization
$43.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Buy

Company Overview

HeartBeam Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

BEAT MarketRank™: 

HeartBeam scored higher than 32% of companies evaluated by MarketBeat, and ranked 740th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HeartBeam has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    HeartBeam has received no research coverage in the past 90 days.

  • Read more about HeartBeam's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HeartBeam is -1.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HeartBeam is -1.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    HeartBeam has a P/B Ratio of 21.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.51% of the float of HeartBeam has been sold short.
  • Short Interest Ratio / Days to Cover

    HeartBeam has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HeartBeam has recently increased by 12.20%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    HeartBeam does not currently pay a dividend.

  • Dividend Growth

    HeartBeam does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.51% of the float of HeartBeam has been sold short.
  • Short Interest Ratio / Days to Cover

    HeartBeam has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HeartBeam has recently increased by 12.20%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    6 people have searched for BEAT on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HeartBeam insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.04% of the stock of HeartBeam is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.77% of the stock of HeartBeam is held by institutions.

  • Read more about HeartBeam's insider trading history.
Receive BEAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HeartBeam and its competitors with MarketBeat's FREE daily newsletter.

BEAT Stock News Headlines

IBN Coverage: HeartBeam (NASDAQ: BEAT) Is One to Watch
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
HeartBeam Reports First Quarter 2025 Results
See More Headlines

BEAT Stock Analysis - Frequently Asked Questions

HeartBeam, Inc. (NASDAQ:BEAT) released its quarterly earnings results on Tuesday, May, 13th. The medical research company reported ($0.18) EPS for the quarter.
Read the conference call transcript
.

HeartBeam (BEAT) raised $16 million in an initial public offering (IPO) on Thursday, November 11th 2021. The company issued 2,750,000 shares at $5.50-$6.50 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that HeartBeam investors own include NVIDIA (NVDA), Meta Platforms (META), Bristol Myers Squibb (BMY), Intel (INTC), Micron Technology (MU), PayPal (PYPL) and AbbVie (ABBV).

Company Calendar

Last Earnings
5/13/2025
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
N/A
Current Symbol
NASDAQ:BEAT
CIK
1574774
Fax
N/A
Employees
1,700
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$8.00
Potential Upside/Downside
+517.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.45 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.06 per share
Price / Book
21.58

Miscellaneous

Free Float
27,711,000
Market Cap
$43.78 million
Optionable
Not Optionable
Beta
-0.70
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:BEAT) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners